Article Information
History
- July 11, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Xikang Fan1,*,
- Cheng Yin2,*,
- Jiayu Wang1,
- Mingjia Yang1,
- Hongxia Ma1,3,4,
- Guangfu Jin1,3,4,
- Mingyang Song5,6,7,
- Zhibin Hu1,3,4,
- Hongbing Shen1,4 and
- Dong Hang1,4,#
- 1Department of Epidemiology and Biostatistics, International Joint Research Center on Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China, 211166
- 2Department of Laboratory, Jiangning Hospital Affiliated to Nanjing Medical University, Nanjing, China, 211100
- 3State Key Laboratory of Reproductive Medicine, Center for Global Health, Nanjing Medical University, Nanjing, China, 211166
- 4Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, China, 211166
- 5Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA, 02115
- 6Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA, 02115
- 7Clinical and Translational Epidemiology Unit and Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA, 02114
- ↵#Correspondence:
Dong Hang, PhD, Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, Center for Global Health, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, China., Email: hangdong{at}njmu.edu.cn
Posted July 11, 2020.
Pre-diagnostic circulating concentrations of insulin-like growth factor-1 and risk of COVID-19 mortality: results from UK Biobank
